Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Privia Health GroupPRVA +0.61%88 EV-to-EBIT is 76.02 as of Jul. 29, 2026, which is 19% below its 10-year median of 94.41. GuruFocus rates PRVA with a GF Score™ of 88/100 and a GF Value™ of $27.58 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Privia Health Group ranks worse than 90.87% on this metric.
Privia Health Group (NAS:PRVA) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Privia Health Group's Enterprise Value for the quarter that ended in Mar. 2026 was $2,228 Mil.
Privia Health Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $36 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Privia Health Group EV-to-EBIT Related Terms
Privia Health Group EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Privia Health Group's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Privia Health Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Privia Health Group EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Privia Health Group's EV-to-EBIT falls into.
Privia Health Group's current Enterprise Value is $2,770 Mil.
Privia Health Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $36 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Privia Health Group (PRVA) has a EV-to-EBIT of 76.02 as of Jul. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Privia Health Group and its competitors. This is 19% below median its historical median of 94.41. According to the industry distribution chart, Privia Health Group ranks #428 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 90.9%.
Is Privia Health Group's EV-to-EBIT too high?
Privia Health Group's current EV-to-EBIT of 76.02 is 19% below median its 10-year median of 94.41. The Healthcare Providers & Services industry median EV-to-EBIT is 15.74. Privia Health Group's value of 76.02 is 383% above this industry median. Based on the distribution chart, Privia Health Group ranks #428 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Privia Health Group has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Privia Health Group's EV-to-EBIT compare to DOCS and WAY?
According to the Healthcare Providers & Services industry distribution chart, Privia Health Group ranks #428 out of 471 companies for EV-to-EBIT. This places Privia Health Group in the lower half of its industry. The industry median EV-to-EBIT is 15.74. Privia Health Group's value of 76.02 is 383% above this benchmark. While the company's 10-year median is 94.41 vs. the industry median of 15.74, Privia Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.74, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Privia Health Group's current EV-to-EBIT of 76.02 is 383% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Privia Health Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Privia Health Group's current EV-to-EBIT is 76.02, which is 19% below median its own 10-year median of 94.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Privia Health Group stock overvalued right now?
Based on GuruFocus' analysis, Privia Health Group (PRVA) is currently considered Modestly Undervalued. The stock's GF Value™ is $27.58, compared to a current price of $24.82 — trading 10% below its estimated fair value. The current EV-to-EBIT is 76.02, which is 19% below median its 10-year median of 94.41 and 383% above the Healthcare Providers & Services industry median of 15.74. Privia Health Group's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Privia Health Group (PRVA), the current EV-to-EBIT is 76.02 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Privia Health Group (PRVA) Overvalued in 2026?
Based on GuruFocus' analysis, Privia Health Group stock appears to be undervalued.
The current stock price of $24.82 is trading 10% below its estimated GF Value™ of $27.58.
GuruFocus considers Privia Health Group to be Modestly Undervalued.
Key valuation signals for PRVA:
EV-to-EBIT: 76.02 (19% below median its 10-year median of 94.41)
GF Value™: $27.58 vs. price of $24.82 (10% below fair value)
Industry Position: 383% above the Healthcare Providers & Services median (#428 of 471)
No single metric tells the full story. See the PRVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
88GF Score
Get the complete analysis for PRVA
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRVA has been successfully added to your 
